14 February 2021 - Japan formally approved Pfizer Inc's coronavirus vaccine on Sunday, the first greenlit for domestic use, clearing ...
25 January 2021 - 88% of patients on Calquence remained free of disease progression after 12 months vs. 68% for ...
22 January 2021 - BioCryst Pharmaceuticals today announced that the Ministry of Health, Labor and Welfare in Japan has granted ...
22 January 2021 - Approval based on phase 2 study conducted in Japan and previous pivotal trial data. ...
8 January 2021 - Myriad Genetics announced today that it received its first reimbursement decision for the Myriad myChoice Diagnostic System, ...
5 January 2020 - Daiichi Sankyo and the University of Tokyo are collaboratively developing teserpaturev, which has received SAKIGAKE designation and ...
28 December 2020 - Approvals based on the PAOLA-1, PROfound and POLO Phase III trials ...
17 December 2020 - Japanese Finance Minister Taro Aso and health minister Norihisa Tamura agreed Thursday to reduce state-set prices ...
27 November 2020 - Approval by MHLW provides new HIF-PH inhibitor treatment option for healthcare providers and adult patients with ...
30 November 2020 - Forxiga is the first SGLT2 inhibitor approved in Japan for chronic heart failure with reduced ejection ...
18 November 2020 - Kaken plans to launch Ecclock for the treatment of primary axillary hyperhidrosis in Japan on 26 November ...
18 November 2020 - Kyowa Kirin today announced that Sandoz KK, its strategic partner of the anti-CD20 monoclonal antibody rituximab ...
19 October 2020 - Fujifilm said it was seeking approval for its flu drug Avigan as a treatment for COVID-19 in ...
25 September 2020 - Ultomiris is the first and only long-acting C5 inhibitor for atypical haemolytic uraemic syndrome, reducing the treatment ...
25 September 2020 - Approval of SAKIGAKE designated medicine is based on pivotal phase 2 DESTINY-Gastric01 trial and represents second approval ...